Publications and Posters

Published Papers and Industry Posters

Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension
Richard A. Lewis, Brian Levy, Nancy Ramirez, Casey C. Kopczynski, Dale W. Usner, Gary D. Novack for the PG324-CS201 Study Group
British Journal of Ophthalmology, Published July 2015
The Clinical Data Management Process
Aron Shapiro, Dale W. Usner
Retina Today, February 2015
A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs and Symptoms in a Dry Eye Population
Kirk Bateman, George W. Ousler, Michael Watson, Keith J. Lane, Donna L. Welch
ARVO Annual Meeting, May 2015
Power and Sample Size Calculations for Primary Open Angle Glaucoma / Ocular Hypertension Clinical Trials Accounting for Correlation of Measures among the Time Points across Visits
Dale W. Usner, Richard Abelson
ARVO Annual Meeting, May 2014
Evaluation of Methods Handling Missing Diary Data for Statistical Analysis in Dry Eye Studies
Hui-Chun T. Hsu, Dale Usner, Richard Abelson
ARVO Annual Meeting, May 2013
A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye
Charles P. Semba, Gail L. Torkildsen, John D. Lonsdale, Eugene B. McLaurin, Joel A. Geffin, Thomas K. Mundorf, Kathryn S. Kennedy, George W. Ousler
American Journal of Ophthalmology, Published February 2012
Statistical Methods for Non-Detectible Data in Tear Cytokine Measurements
Heidi Goldfarb, Dale Usner, Kathryn Kennedy, Dale Kennedy, Richard Abelson
ARVO Annual Meeting, May 2012
Evaluation and Selection of Statistical Analyses for Diary Data in Dry Eye Studies
Hui-Chun T. Hsu, Kathryn S. Kennedy, Dale Usner, Dale J. Kennedy, Richard Abelson
ARVO Annual Meeting, May 2012
Ophthalmic Study Population Trends
Beverly A. Mersing, Dale J. Kennedy, Richard B. Abelson, Mark E. Talbert, Kathryn S. Kennedy, Dale W. Usner
ARVO Annual Meeting, May 2012
Sample Size and Power Tabulations in Dry Eye Clinical Trials
Nuttha Lurponglukana-Strand, Dale Usner, Kathryn S. Kennedy, Dale J. Kennedy, Richard Abelson
ARVO Annual Meeting, May 2012
Multi-Dimensional Testing to deal with Multiplicity in Clinical Trials
Swetha Surabhi, Dale Usner, Dale Kennedy, Kathryn Kennedy, Richard Abelson
ARVO Annual Meeting, May 2012

Publications and Posters

Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension

The Clinical Data Management Process

A Mixed Model, Repeated Measure Analysis of Demographics and Dry Eye Signs and Symptoms in a Dry Eye Population

Power and Sample Size Calculations for Primary Open Angle Glaucoma / Ocular Hypertension Clinical Trials Accounting for Correlation of Measures among the Time Points across Visits

Evaluation of Methods Handling Missing Diary Data for Statistical Analysis in Dry Eye Studies

A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye

Statistical Methods for Non-Detectible Data in Tear Cytokine Measurements

Evaluation and Selection of Statistical Analyses for Diary Data in Dry Eye Studies

Ophthalmic Study Population Trends

Sample Size and Power Tabulations in Dry Eye Clinical Trials

Multi-Dimensional Testing to deal with Multiplicity in Clinical Trials

Content by Categories

Publications and Posters

Webinars

Case Studies

Brochures

Contact Information

Quick Links